| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2017PLoSO..1271572M |
| P356 | DOI | 10.1371/JOURNAL.PONE.0171572 |
| P932 | PMC publication ID | 5302377 |
| P698 | PubMed publication ID | 28187204 |
| P50 | author | Rob J Center | Q89251682 |
| Damian Purcell | Q89251683 | ||
| John M. Murray | Q41046114 | ||
| P2093 | author name string | Kazuo Suzuki | |
| Anthony D Kelleher | |||
| Stephen Maher | |||
| Talia Mota | |||
| P2860 | cites work | Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. | Q55244204 |
| Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120 | Q72067428 | ||
| HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells | Q22251066 | ||
| Correlated mutations and residue contacts in proteins | Q25891592 | ||
| Genome-wide hepatitis C virus amino acid covariance networks can predict response to antiviral therapy in humans | Q27487540 | ||
| Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 | Q27644478 | ||
| Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus | Q27644501 | ||
| Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 | Q27663293 | ||
| Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer | Q27680496 | ||
| Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer | Q27680497 | ||
| Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike | Q27683540 | ||
| Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody | Q27759364 | ||
| Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells | Q28288205 | ||
| Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand | Q29547531 | ||
| Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection | Q29619510 | ||
| A pair-to-pair amino acids substitution matrix and its applications for protein structure prediction. | Q30359373 | ||
| Analysis of the residue-residue coevolution network and the functionally important residues in proteins. | Q30367758 | ||
| Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection | Q33504604 | ||
| Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection | Q33825654 | ||
| The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmission | Q33839456 | ||
| A signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivity | Q34005516 | ||
| Identifying and characterizing recently transmitted viruses | Q34038460 | ||
| Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections | Q34042642 | ||
| Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection | Q34228730 | ||
| The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. | Q34341843 | ||
| Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface | Q34473958 | ||
| Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended | Q34574305 | ||
| Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection | Q34641933 | ||
| Genotype 1 hepatitis C virus envelope features that determine antiviral response assessed through optimal covariance networks. | Q34806845 | ||
| Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry | Q35140429 | ||
| Structure and immune recognition of trimeric pre-fusion HIV-1 Env. | Q35142291 | ||
| Comprehensive antigenic map of a cleaved soluble HIV-1 envelope trimer | Q35217426 | ||
| Single amino acid substitution in constant region 1 or 4 of gp120 causes the phenotype of a human immunodeficiency virus type 1 variant with mutations in hypervariable regions 1 and 2 to revert | Q35853972 | ||
| Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1. | Q35857683 | ||
| Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7 | Q36000722 | ||
| Application of a case-control study design to investigate genotypic signatures of HIV-1 transmission | Q36164165 | ||
| Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication | Q36315510 | ||
| HIV-1 subtypes: epidemiology and significance for HIV management | Q36351264 | ||
| Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. | Q36376216 | ||
| Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1. | Q36636717 | ||
| Monitoring alpha4beta7 integrin expression on circulating CD4+ T cells as a surrogate marker for tracking intestinal CD4+ T-cell loss in SIV infection. | Q36985448 | ||
| Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants | Q37145228 | ||
| Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection | Q37273158 | ||
| Selection of HIV variants with signature genotypic characteristics during heterosexual transmission | Q37370674 | ||
| The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. | Q37428017 | ||
| Unique functional properties of conserved arginine residues in the lentivirus lytic peptide domains of the C-terminal tail of HIV-1 gp41. | Q37635804 | ||
| Lessons learned from HIV vaccine clinical efficacy trials | Q37724091 | ||
| The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection | Q38949380 | ||
| Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers | Q39001126 | ||
| Viroporin potential of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41 protein | Q41892359 | ||
| Envelope glycoprotein binding to the integrin α4β7 is not a general property of most HIV-1 strains | Q42206820 | ||
| Correlation of co-ordinated amino acid substitutions with function in viruses related to tobacco mosaic virus | Q44014609 | ||
| Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission | Q47878972 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0171572 | |
| P577 | publication date | 2017-02-10 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Differentiating founder and chronic HIV envelope sequences | |
| P478 | volume | 12 |
Search more.